Pages
- Expertise
- Subject Matter Experts
- Therapeutic Expertise
- Other Therapeutic Areas
- Anesthesia / Respiratory
- Cardiolovascular
- Wound Care
- Dental
- Diabetics
- Diagnostic Imaging
- General Surgery
- Ear / Nose / Throat
- Gastroenterology
- Neurology
- IVD & Companion Diagnostics
- Oncology
- OBSTETRICS & GYNECOLOGY (OB/GYN)
- Ophthalmology
- Orthopedics
- Peripheral Vascular
- Regenerative Medicine
- Home
- Website Accessibility Statement
- Sign Up
- Account
- Services
- Preclinical Research
- Product Development Strategy
- Medical Writing Solutions
- Medical Device Regulatory & Quality
- Medical Device Regulatory & Quality
- Biological Safety
- Medical Device Development in China
- MRO Program
- Medical Device Testing
- Medical Device Reimbursement
- Clinical Research
- IVD
- Medical Device Testing
- APS
- ÅKRN
- Clinlogix
- Medanex
- European Union’s General Data Protection Regulation Frequently Asked Questions – Vendors
- European Union’s General Data Protection Regulation Frequently Asked Questions – Clients
- Syntactx
- Resources
- Checklists and Sample Submission Forms
- COVID-19 Resources
- Medical Device Development Podcasts
- BiocompCHATibility Podcast
- Biocompchatibility – Welcome
- CSI: Cracking the Case
- Extractions: The How and Why
- FDA Thoughts On Chemical Characterization
- Don’t Forget Packaging!
- Welcome to NAMSA: Lisa Olson
- Editor Chat: Biocompatibility and Performance of Medical Devices
- NAMSA Training Series: Live from Philadelphia
- NAMSA Training Series: Live from Frankfurt
- Discussion with Chemical Characterization “A-Lister” Ted Heise on the New ISO 10993-18
- Reusable Devices and the Challenges with Biocompatibility
- Answering Your Questions on ISO 10993-18:2020
- The QB1 of GLP
- Biological Equivalency: When is “same” the same?
- The Biological Evaluation Plan: A Manufacturer’s Perspective with Guest Dave Parente of Ecolab
- Biocomp and Beer
- NAMSA Awarded ASCA Accreditation
- Covid 19: Biocompatibility of Ventilators and Respiratory Devices
- Biocompatibility FAQ
- Listener MailBag – We Answer Your Questions
- FDA and ISO 10993-18:2020
- Why Biocompatibility Cares about Preclinical: NAMSA and APS Discuss
- When to Go with In Vitro: Your Irritation Questions Answered
- Oh No, Another Failed Cyto!
- Is your Biocompatibility Program Knocking your Submission Off Track?
- The Facts About In Vitro Irritation
- Intact Skin Contact Devices: To Test or Not to Test
- What in the World is the FDA’s Lab Accreditation Program – ASCA?
- ISO 10993-4: The Second Most Misunderstood Section of 10993
- Finding the Qualified Biocompatibility Unicorn
- Biocompatibility and the Pre-Submission Meeting – The Devil is in the Details
- A Start-up Biocompatibility Story – Prescient Surgical
- Navigating the MedTech Start-Up World Podcast
- BiocompCHATibility Podcast
- IVDR Planning Resources
- EU MDR & IVDR Planning Resources
- Blog
- Resource Library
- NAMSA Medical Device Test Navigators
- E-Learning
- Subject Matter Expert Consultation
- Contact
- About
- Careers
- Events
- NAMSA’s Client Standard Terms and Conditions
- EU-U.S. & Swiss-U.S Privacy Shield
- Certifications and Accreditations
- Website Terms of Use
- Site Map
- NAMSA Purchasing Terms and Conditions
- Website Privacy Statement